Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study

Author:

Bor JacobORCID,Assoumou Sabrina A.,Lane KevinORCID,Diaz YarelizORCID,Ojikutu Bisola O.,Raifman Julia,Levy Jonathan I.ORCID

Abstract

Background Inequities in Coronavirus Disease 2019 (COVID-19) vaccine and booster coverage may contribute to future disparities in morbidity and mortality within and between Massachusetts (MA) communities. Methods and findings We conducted a population-based cross-sectional study of primary series vaccination and booster coverage 18 months into the general population vaccine rollout. We obtained public-use data on residents vaccinated and boosted by ZIP code (and by age group: 5 to 19, 20 to 39, 40 to 64, 65+) from MA Department of Public Health, as of October 10, 2022. We constructed population denominators for postal ZIP codes by aggregating census tract population estimates from the 2015–2019 American Community Survey. We excluded nonresidential ZIP codes and the smallest ZIP codes containing 1% of the state’s population. We mapped variation in ZIP code-level primary series vaccine and booster coverage and used regression models to evaluate the association of these measures with ZIP code-level socioeconomic and demographic characteristics. Because age is strongly associated with COVID-19 severity and vaccine access/uptake, we assessed whether observed socioeconomic and racial/ethnic inequities persisted after adjusting for age composition and plotted age-specific vaccine and booster coverage by deciles of ZIP code characteristics. We analyzed data on 418 ZIP codes. We observed wide geographic variation in primary series vaccination and booster rates, with marked inequities by ZIP code-level education, median household income, essential worker share, and racial/ethnic composition. In age-stratified analyses, primary series vaccine coverage was very high among the elderly. However, we found large inequities in vaccination rates among younger adults and children, and very large inequities in booster rates for all age groups. In multivariable regression models, each 10 percentage point increase in “percent college educated” was associated with a 5.1 (95% confidence interval (CI) 3.9 to 6.3, p < 0.001) percentage point increase in primary series vaccine coverage and a 5.4 (95% CI 4.5 to 6.4, p < 0.001) percentage point increase in booster coverage. Although ZIP codes with higher “percent Black/Latino/Indigenous” and higher “percent essential workers” had lower vaccine coverage (−0.8, 95% CI −1.3 to −0.3, p < 0.01; −5.5, 95% CI −7.3 to −3.8, p < 0.001), these associations became strongly positive after adjusting for age and education (1.9, 95% CI 1.0 to 2.8, p < 0.001; 4.8, 95% CI 2.6 to 7.1, p < 0.001), consistent with high demand for vaccines among Black/Latino/Indigenous and essential worker populations within age and education groups. Strong positive associations between “median household income” and vaccination were attenuated after adjusting for age. Limitations of the study include imprecision of the estimated population denominators, lack of individual-level sociodemographic data, and potential for residential ZIP code misreporting in vaccination data. Conclusions Eighteen months into MA’s general population vaccine rollout, there remained large inequities in COVID-19 primary series vaccine and booster coverage across MA ZIP codes, particularly among younger age groups. Disparities in vaccination coverage by racial/ethnic composition were statistically explained by differences in age and education levels, which may mediate the effects of structural racism on vaccine uptake. Efforts to increase booster coverage are needed to limit future socioeconomic and racial/ethnic disparities in COVID-19 morbidity and mortality.

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference34 articles.

1. Goodman B. Coronavirus: As BA.2 subvariant of Omicron rises, lab studies point to signs of severity | CNN. In: CNN [Internet]. 2022 Feb 19 [cited 2022 Mar 3]. https://www.cnn.com/2022/02/17/health/ba-2-covid-severity/index.html.

2. Parker-Pope T, Sheikh K. A New Wave of Covid-19 Is Coming. Here’s How to Prepare. New York Times. 2022 Mar 30. https://www.nytimes.com/2022/03/30/well/live/ba2-omicron-covid.html?campaign_id=190&emc=edit_ufn_20220404&instance_id=57583&nl=updates-from-the-newsroom®i_id=60664908&segment_id=87482&te=1&user_id=56cb50d751cf7e19446c75795338e20b.

3. Uncoupling of all-cause excess mortality from COVID-19 cases in a highly vaccinated state;JS Faust;Lancet Infect Dis,2022

4. Kaiser Family Foundation (Institution). KFF COVID-19 Vaccine Monitor Dashboard. [cited 2022 Apr 5]. https://www.kff.org/coronavirus-covid-19/dashboard/kff-covid-19-vaccine-monitor-dashboard/.

5. Racial/Ethnic Disparities in State-Level COVID-19 Vaccination Rates and Their Association with Structural Racism;M Siegel;J Racial Ethn Health Disparities,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3